Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001059827 | SCV001224475 | likely benign | not provided | 2023-10-05 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001123578 | SCV001282428 | uncertain significance | Hereditary spherocytosis type 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127676 | SCV001287013 | uncertain significance | Hemolytic anemia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127677 | SCV001287014 | benign | Autosomal dominant distal renal tubular acidosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
ARUP Laboratories, |
RCV001059827 | SCV002049807 | uncertain significance | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001059827 | SCV003821420 | uncertain significance | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001059827 | SCV004224379 | uncertain significance | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005012507 | SCV005642235 | uncertain significance | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2024-04-23 | criteria provided, single submitter | clinical testing |